ArticleMethods in molecular biology (Clifton, N.J.)2026
Instance and Feature Selection: Algorithmic Identification of Unique Kinase Protein Interactions from the Protein Data Bank (PDB) and Their Features.
Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Use of two novel Machine Learning algorithms, Simultaneous perturbation Instance Selection (SpIS) and Simultaneous perturbation Feature and Instance Selection (SpFIS) enabled identification (and visualization) of unique Kinase Protein Interactions (KPIs), so-called instances and their features. The resultant minimal subset of both instances and features, based on the full data set of n = 188 KPIs and p = 83 features, successfully characterized the six human kinase groups: KG = 1 (TK), KG = 2 (Other), KG = 3 (CAMK), KG = 4 (AGC), KG = 5 (CMGC), KG = 6 (STE). A new partition of eight groups of KPIs based on deep Gaussian mixture clustering (deepGMM, M1DGMM), and a parsimonious reduced data set of 35 peptide-centric interaction features for the full 188 KPIs, also well characterized by a minimal subset of instances and features. Irrespective of the target groups, whether the six human kinase groups or the eight M1DGMM partition, the minimal subsets selection chose between 10 and 12 unique KPIs (with high fivefold cross validation accuracy). Also, minimal subset selection provided between 13 and 19 features (with high fivefold cross validation accuracy). Importantly, the minimal subsets of instances and features derived from SpFIS and SpIS differed according to whether the target group was Kinase group or M1DGMM. This highlights the value of our new classification based on DGMM. KPIs such as 3ALO, 1UKI, and 4UBX, so-called outliers, gave further insights into structural differences with potential to add to drug discovery innovation. There is potential for other peptide-protein sets (not just Kinases) to be similarly explored, with extensions to protein-protein (not just peptide) interactions.
Indexed as
Identifiers
42680987What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.